14 May 2024
MaaT Pharma Launches a Global Offering of approximately 18 Million Euros
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...